211 related articles for article (PubMed ID: 22900632)
1. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease.
Belibasakis GN; Rechenberg DK; Zehnder M
Int Endod J; 2013 Feb; 46(2):99-111. PubMed ID: 22900632
[TBL] [Abstract][Full Text] [Related]
2. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
Menezes R; Bramante CM; da Silva Paiva KB; Letra A; Carneiro E; Fernando Zambuzzi W; Granjeiro JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
[TBL] [Abstract][Full Text] [Related]
4. [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis].
Fan R; Zhang CF; Gao Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):39-42. PubMed ID: 18278135
[TBL] [Abstract][Full Text] [Related]
5. Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis.
Rechenberg DK; Bostanci N; Zehnder M; Belibasakis GN
Cytokine; 2014 Sep; 69(1):116-9. PubMed ID: 25022970
[TBL] [Abstract][Full Text] [Related]
6. Levels of oxidative stress biomarkers and bone resorption regulators in apical periodontitis lesions infected by Epstein-Barr virus.
Jakovljevic A; Andric M; Nikolic N; Coric V; Krezovic S; Carkic J; Knezevic A; Beljic-Ivanovic K; Pljesa-Ercegovac M; Miletic M; Soldatovic I; Radosavljevic T; Jovanovic T; Simic T; Ivanovic V; Milasin J
Int Endod J; 2018 Jun; 51(6):593-604. PubMed ID: 29315650
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin.
Liu L; Zhang C; Hu Y; Peng B
J Endod; 2012 Jul; 38(7):943-7. PubMed ID: 22703658
[TBL] [Abstract][Full Text] [Related]
8. Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure.
Estrela C; Decurcio Dde A; Silva JA; Batista AC; de Souza Lima NC; de Freitas Silva BS; de Souza JA; Souza Costa CA
J Endod; 2016 Mar; 42(3):439-46. PubMed ID: 26806398
[TBL] [Abstract][Full Text] [Related]
9. The RANKL-OPG system in clinical periodontology.
Belibasakis GN; Bostanci N
J Clin Periodontol; 2012 Mar; 39(3):239-48. PubMed ID: 22092994
[TBL] [Abstract][Full Text] [Related]
10. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
11. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation.
Salbach-Hirsch J; Kraemer J; Rauner M; Samsonov SA; Pisabarro MT; Moeller S; Schnabelrauch M; Scharnweber D; Hofbauer LC; Hintze V
Biomaterials; 2013 Oct; 34(31):7653-61. PubMed ID: 23871544
[TBL] [Abstract][Full Text] [Related]
12. Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines.
Duka M; Eraković M; Dolićanin Z; Stefanović D; Čolić M
Mediators Inflamm; 2019; 2019():8325380. PubMed ID: 31011287
[TBL] [Abstract][Full Text] [Related]
13. Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions.
Chuang FH; Tsai CC; Chen JH; Chen KK; Chen YK; Lin YC
J Oral Pathol Med; 2012 Feb; 41(2):186-93. PubMed ID: 21793936
[TBL] [Abstract][Full Text] [Related]
14. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions.
Menezes R; Garlet TP; Letra A; Bramante CM; Campanelli AP; Figueira Rde C; Sogayar MC; Granjeiro JM; Garlet GP
J Endod; 2008 Aug; 34(8):932-8. PubMed ID: 18634923
[TBL] [Abstract][Full Text] [Related]
15. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of the receptor activator of NF-κB ligand and osteoprotegerin and the number of gram-negative bacteria in symptomatic and asymptomatic periapical lesions.
Carneiro E; Parolin AB; Wichnieski C; Rosa EA; Silva Neto UX; Westphalen VP; Fariniuk LF; Johann AC
Arch Oral Biol; 2017 Jan; 73():166-171. PubMed ID: 27771584
[TBL] [Abstract][Full Text] [Related]
18. Notch Signaling Pathway in Apical Periodontitis: Correlation with Bone Resorption Regulators and Proinflammatory Cytokines.
Nikolic N; Jakovljevic A; Carkic J; Beljic-Ivanovic K; Miletic M; Soldatovic I; Andric M; Ivanovic V; Milasin J
J Endod; 2019 Feb; 45(2):123-128. PubMed ID: 30580840
[TBL] [Abstract][Full Text] [Related]
19. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
20. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis.
Silva JA; Lopes Ferrucci D; Peroni LA; de Paula Ishi E; Rossa-Junior C; Carvalho HF; Stach-Machado DR
Cells Tissues Organs; 2012; 196(2):137-50. PubMed ID: 22301390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
